We are live on ! Find out more
NVAX icon

Novavax
NVAX

201 hedge funds and large institutions have $371M invested in Novavax in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 73 increasing their positions, 43 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more call options, than puts

Call options by funds: $214M | Put options by funds: $94.8M

70% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 43

14% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 28

1% more funds holding

Funds holding: 199 → 201 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less capital invested

Capital invested by funds: $411M → $371M (-$39.4M)

16.64% less ownership

Funds ownership: 71.6% → 54.96% (-17%)

Holders
201
Holders Change
+2
Holders Change %
+1.01%
% of All Funds
2.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
73
Reduced
43
Closed
28
Calls
$214M
Puts
$94.8M
Net Calls
+$119M
Net Calls Change
+$118M

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$5.25M
2
BlackRock
BlackRock
New York
+$4.6M
3
UBS Group
UBS Group
Switzerland
+$4.59M
4
Allianz Asset Management
Allianz Asset Management
Germany
+$3.87M
5
Citigroup
Citigroup
New York
+$2.61M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$58.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$4.95M
3
Jane Street
Jane Street
New York
-$4.66M
4
Barclays
Barclays
United Kingdom
-$2.64M
5
Millennium Management
Millennium Management
New York
-$1.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIS
176
Sound Income Strategies
Florida
$335 – – –
IWP
177
IAG Wealth Partners
Wisconsin
$292 – – –
HNB
178
Huntington National Bank
Ohio
$287 +$278 +60 +6,000%
EWA
179
EverSource Wealth Advisors
Alabama
$260 – – –
BTI
180
Blue Trust Inc
Georgia
$239 -$121 -26 -34%
OPTFSNA
181
Old Point Trust & Financial Services N A
Virginia
$239 +$232 +50 New
GRP
182
Global Retirement Partners
California
$229 -$4.64K -1,000 -95%
SSB
183
Sandy Spring Bank
Maryland
$216 – – –
HNB
184
Hilltop National Bank
Wyoming
$167 +$162 +35 New
PWMG
185
Prestige Wealth Management Group
New Jersey
$139 – – –
CJ
186
Caitlin John
Michigan
$120 – – –
CSC
187
Caldwell Sutter Capital
California
$120 – – –
TIM
188
Tortoise Investment Management
New York
$120 – – –
FGAM
189
Financial Gravity Asset Management
Texas
$102 +$74 +16 +267%
AWM
190
Avior Wealth Management
Nebraska
$81 +$79 +17 New
CFD
191
Creative Financial Designs
Indiana
$57 – – –
BWL
192
Bogart Wealth LLC
Virginia
$48 – – –
QC
193
Quent Capital
New York
$43 -$23 -5 -36%
SWA
194
SOA Wealth Advisors
New York
$38 – – –
CPG
195
Cornerstone Planning Group
New Jersey
$10 – – –
RCM
196
Raleigh Capital Management
North Carolina
$10 – – –
GFPC
197
Global Financial Private Client
Florida
$5 – – –
BMC
198
Bear Mountain Capital
Washington
$4 -$83 -18 -95%
M
199
Murchinson
Ontario, Canada
– -$480K -100,000 Closed
BFM
200
Boothbay Fund Management
New York
– -$257K -53,506 Closed
6 7
8
9 10

NVAX Hedge Fund Activity: Q1 2024 in Review

201 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2024, worth a combined $371M — down 9.6% from $411M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NVAX positions and 28 closed out — a net gain of 4 holders — while 73 added to existing stakes and 43 trimmed.

The largest buyer was Farallon Capital Management, opening a new position worth an estimated $5.25M. The largest seller was Morgan Stanley, cutting an estimated $58.5M.

  • 201 institutional investors held Novavax (NVAX) as of Q1 2024, up from 199 in Q4 2023.
  • Funds reported $371M of Novavax stock for Q1 2024, down 9.6% quarter-over-quarter.
  • 32 funds opened new Novavax positions in Q1 2024 and 28 closed out, a net change of +4 holders.
  • The largest Novavax buyer in Q1 2024 was Farallon Capital Management, an estimated $5.25M added.
  • The largest Novavax seller in Q1 2024 was Morgan Stanley, an estimated $58.5M sold.

Based on aggregated 13F filings for Q1 2024.